Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
Twitter Feed
-
"Being part of this dynamic and innovative company is inspiring and enriching. It is gratifying to learn something new every day." - Louca, Scientist https://t.co/tU64wKRGmI
— UCB News (@ucb_news) 11.07.2019 -
We are looking for talents to help connect people, information and technology. Do you think you have what it takes? Learn more at https://t.co/5H2nLGGVKB https://t.co/QUgRr1HJhv
— UCB News (@ucb_news) 05.07.2019 -
Another key message from @Erikwits Head Innovation Solutions @UCB on the importance of ecosystems joining forces to provide solutions for patients. Watch the clip from #HIMSSEurope2019 https://t.co/NH0Jv4Sduq
— UCB News (@ucb_news) 01.07.2019
